Gumulka Jerzy 4/A
4/A · CNS Pharmaceuticals, Inc. · Filed Oct 12, 2023
Insider Transaction Report
Form 4/AAmended
Gumulka Jerzy
Director
Transactions
- Award
Option to purchase common stock
2023-09-21+39,475→ 45,428 totalExercise: $1.09Exp: 2033-09-22→ Common Stock (39,475 underlying)
Footnotes (2)
- [F1]The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
- [F2]The stock options were issued in connection with the reporting person's Board of Director services to the Company.